Home
ELEV
ELEV News

Latest Elevation Oncology Inc. Common stock (ELEV) News on July 7, 2025

MT Newswires

a month ago

TD Cowen Downgrades Elevation Oncology to Hold From Buy

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right

PR Newswire

a month ago

Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

PR Newswire

2 months ago

Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Zacks

2 months ago

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

PR Newswire

2 months ago

Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

GSK prepares to relaunch Blenrep; Activists challenge another ‘zombie’ biotech

BioPharma Dive

3 months ago

GSK prepares to relaunch Blenrep; Activists challenge another ‘zombie’ biotech

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

PR Newswire

3 months ago

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

MT Newswires

3 months ago

Stephens Downgrades Elevation Oncology to Equal Weight From Overweight, Adjusts Price Target to $1 From $5

Elevation Oncology Plunges 42% on Ending Development of Lead Drug

Zacks

4 months ago

Elevation Oncology Plunges 42% on Ending Development of Lead Drug

Investing.com

4 months ago

Elevation Oncology downgraded as it halts lead asset on disappointing trials

MT Newswires

4 months ago

Piper Sandler Downgrades Elevation Oncology to Neutral From Overweight, Adjusts Price Target to $0.70 From $10

Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options

PR Newswire

4 months ago

Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

PR Newswire

4 months ago

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology to Participate in Upcoming Investor Conferences

PR Newswire

4 months ago

Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

PR Newswire

6 months ago

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

Why Elevation Oncology (ELEV) Is Among the Best Penny Stocks to Invest In According to Media?

Insider Monkey

6 months ago

Why Elevation Oncology (ELEV) Is Among the Best Penny Stocks to Invest In According to Media?

MT Newswires

6 months ago

William Blair Initiates Elevation Oncology at Outperform

Bipartisan lawmakers appear 'aligned' on PBM, insurance reform

Yahoo Finance Video

7 months ago

Bipartisan lawmakers appear 'aligned' on PBM, insurance reform

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

PR Newswire

7 months ago

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

PR Newswire

7 months ago

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

PR Newswire

7 months ago

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

PR Newswire

8 months ago

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

What Makes Elevation Oncology (ELEV) a New Strong Buy Stock

Zacks

9 months ago

What Makes Elevation Oncology (ELEV) a New Strong Buy Stock

Empery Asset Management's Strategic Acquisition in Elevation Oncology

GuruFocus.com

9 months ago

Empery Asset Management's Strategic Acquisition in Elevation Oncology

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

PR Newswire

9 months ago

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

10 months ago

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours

Clinical Trials Arena

a year ago

Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours

Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements

PR Newswire

a year ago

Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2

PR Newswire

a year ago

Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer

PR Newswire

a year ago

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

MT Newswires

a year ago

Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target

MT Newswires

a year ago

Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference

PR Newswire

a year ago

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements

PR Newswire

a year ago

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024

PR Newswire

a year ago

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024

GuruFocus.com

a year ago

Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements

PR Newswire

a year ago

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements

Trim the Fat: 3 Overbought Stocks Poised for a Pullback

InvestorPlace

a year ago

Trim the Fat: 3 Overbought Stocks Poised for a Pullback

Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

PR Newswire

a year ago

Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors

PR Newswire

a year ago

Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors

Elevation Oncology to Participate in Upcoming Investor Conferences

PR Newswire

a year ago

Elevation Oncology to Participate in Upcoming Investor Conferences

3 Stock Winners That Are Up 400% or More in 2024

InvestorPlace

a year ago

3 Stock Winners That Are Up 400% or More in 2024

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

PR Newswire

a year ago

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

Why ChargePoint, Lucid, and Fisker Stocks All Fell in January

Motley Fool

a year ago

Why ChargePoint, Lucid, and Fisker Stocks All Fell in January

RADCOM Ltd. (NASDAQ:RDCM) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

RADCOM Ltd. (NASDAQ:RDCM) Q4 2023 Earnings Call Transcript

Wasabi Partner Network Awards Honors Climb Channel Solutions

GlobeNewswire

a year ago

Wasabi Partner Network Awards Honors Climb Channel Solutions

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

StockStory

a year ago

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

Associated Press Finance

a year ago

Riverview Bancorp: Fiscal Q3 Earnings Snapshot

Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024

GlobeNewswire

a year ago

Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024

Energy Vault Expands Global Footprint for Gravity Energy Storage with 10 Year License and Royalty Agreement Covering Southern Africa

Business Wire

a year ago

Energy Vault Expands Global Footprint for Gravity Energy Storage with 10 Year License and Royalty Agreement Covering Southern Africa

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

GlobeNewswire

a year ago

IBN Announces Latest Episode of The Stock2Me Podcast featuring Dr. Alan Baratz, CEO of D-Wave Quantum Inc.

Associated Press Finance

a year ago

Bridgewater: Q4 Earnings Snapshot

Bridgewater Bancshares, Inc. Announces Fourth Quarter 2023 Net Income of $8.9 Million, $0.28 Diluted Earnings Per Common Share

Business Wire

a year ago

Bridgewater Bancshares, Inc. Announces Fourth Quarter 2023 Net Income of $8.9 Million, $0.28 Diluted Earnings Per Common Share

Best Momentum Stocks to Buy for January 24th

Zacks

a year ago

Best Momentum Stocks to Buy for January 24th

D-Wave Appoints Former Secretary of Homeland Security to Board

NewMediaWire

a year ago

D-Wave Appoints Former Secretary of Homeland Security to Board

Bit Digital, Inc. Announces Commencement of Revenue Generation for Inaugural AI Contract

PR Newswire

a year ago

Bit Digital, Inc. Announces Commencement of Revenue Generation for Inaugural AI Contract

ACCESSWIRE

a year ago

Global Partners for Development and 374Water Announce Partnership Project - The Homa Bay Blueprint: A Beacon for Climate Resilience in Africa

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Business Wire

a year ago

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred units

GlobeNewswire

a year ago

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred units

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

PR Newswire

a year ago

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

Invitae Completes Sale of Reproductive Health Assets to Natera

PR Newswire

a year ago

Invitae Completes Sale of Reproductive Health Assets to Natera

Syntec Optics (Nasdaq: OPTX) Secures $4.8M Order for Medical Diagnostics Optics

GlobeNewswire

a year ago

Syntec Optics (Nasdaq: OPTX) Secures $4.8M Order for Medical Diagnostics Optics

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges

Zacks

a year ago

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

ACCESSWIRE

a year ago

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business

Simply Wall St.

a year ago

With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business

5 Stocks in Focus on Their Recent Dividend Hike

Zacks

a year ago

5 Stocks in Focus on Their Recent Dividend Hike

Climb Channel Solutions Announces Expanded Partnership with Jamf to Offer Apple Device Management and Protection to US Reseller Partners

GlobeNewswire

a year ago

Climb Channel Solutions Announces Expanded Partnership with Jamf to Offer Apple Device Management and Protection to US Reseller Partners

Zacks Small Cap Research

a year ago

CVM: Fiscal Year 2023 in Review

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

PR Newswire

2 years ago

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

Quest Resource Holding (NASDAQ:QRHC) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

2 years ago

Quest Resource Holding (NASDAQ:QRHC) Might Have The Makings Of A Multi-Bagger

How Vistagen (VTGN) Stock Stands Out in a Strong Industry

Zacks

2 years ago

How Vistagen (VTGN) Stock Stands Out in a Strong Industry

13 Most Promising Small-Cap Stocks According to Analysts

Insider Monkey

2 years ago

13 Most Promising Small-Cap Stocks According to Analysts

CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments

Business Wire

2 years ago

CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments

Transforming Waste Management: 374Water’s Year of Milestones and Global Sustainability Leadership

ACCESSWIRE

2 years ago

Transforming Waste Management: 374Water’s Year of Milestones and Global Sustainability Leadership

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

Zacks

2 years ago

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

LivePerson named a Leader across multiple G2 Grid® reports for enterprise conversations

PR Newswire

2 years ago

LivePerson named a Leader across multiple G2 Grid® reports for enterprise conversations

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical

Zacks

2 years ago

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Alpine Immune Sciences, Lyra Therapeutics, Harpoon Therapeutics and Journey Medical

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

Zacks

2 years ago

5 Small Drug Stocks to Buy on Hopes of Better Prospects in the New Year

Comtech Telecommunications Corp. (NASDAQ:CMTL) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Comtech Telecommunications Corp. (NASDAQ:CMTL) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Comtech Telecommunications Corp Earnings Call

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

GlobeNewswire

2 years ago

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Business Wire

2 years ago

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference

PR Newswire

2 years ago

Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference

The First of Long Island Corporation (NASDAQ:FLIC) is favoured by institutional owners who hold 54% of the company

Simply Wall St.

2 years ago

The First of Long Island Corporation (NASDAQ:FLIC) is favoured by institutional owners who hold 54% of the company

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.

2 years ago

Geospace Technologies Corporation's (NASDAQ:GEOS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Intrepid Potash (IPI) Q3 Earnings Lag Estimates, Sales Down Y/Y

Zacks

2 years ago

Intrepid Potash (IPI) Q3 Earnings Lag Estimates, Sales Down Y/Y

Quad Releases 2023 ESG Update

Business Wire

2 years ago

Quad Releases 2023 ESG Update

Seoul National University Opens NuScale Power Energy Exploration Center

Business Wire

2 years ago

Seoul National University Opens NuScale Power Energy Exploration Center

Empire Petroleum Corp (EP) Reports Mixed Q3 2023 Results Amid Strategic Initiatives

GuruFocus.com

2 years ago

Empire Petroleum Corp (EP) Reports Mixed Q3 2023 Results Amid Strategic Initiatives

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

HAMILTON BEACH BRANDS HOLDING COMPANY DECLARES QUARTERLY DIVIDEND AND ANNOUNCES STOCK REPURCHASE PROGRAM

PR Newswire

2 years ago

HAMILTON BEACH BRANDS HOLDING COMPANY DECLARES QUARTERLY DIVIDEND AND ANNOUNCES STOCK REPURCHASE PROGRAM

Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results

PR Newswire

2 years ago

Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results

Share on Social Networks: